EP Patent

EP2233133A1 — Stable Rosuvastatin Compositions

Assigned to Sanovel Ilac Sanayi ve Ticaret AS · Expires 2010-09-29 · 16y expired

What this patent protects

The present invention is relates to novel stable pharmaceutical compositions of rosuvastatin calcium, comprising dicalcium phosphate anhydrous in core and polyethylene glycol in combination with titanium dioxide in coating which is free of ferric oxide.

USPTO Abstract

The present invention is relates to novel stable pharmaceutical compositions of rosuvastatin calcium, comprising dicalcium phosphate anhydrous in core and polyethylene glycol in combination with titanium dioxide in coating which is free of ferric oxide.

Drugs covered by this patent

Patent Metadata

Patent number
EP2233133A1
Jurisdiction
EP
Classification
—
Expires
2010-09-29
Drug substance claim
No
Drug product claim
No
Assignee
Sanovel Ilac Sanayi ve Ticaret AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.